Literature DB >> 32164907

FOLFOXIRI reintroduction in metastatic colorectal cancer.

Rob Glynne-Jones1, Mark Harrison2.   

Abstract

Entities:  

Year:  2020        PMID： 32164907     DOI： 10.1016/S1470-2045(20)30087-5

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  3 in total

1.  Notum palmitoleoyl-protein carboxylesterase regulates Fas cell surface death receptor-mediated apoptosis via the Wnt signaling pathway in colon adenocarcinoma.

Authors:  Hua Gong; Qiang Niu; Yi Zhou; Yun-Xia Wang; Xuan-Fu Xu; Ke-Zhu Hou
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

2.  FOLFOXIRI Resistance Induction and Characterization in Human Colorectal Cancer Cells.

Authors:  George M Ramzy; Laura Boschung; Thibaud Koessler; Céline Delucinge-Vivier; Mylène Docquier; Thomas A McKee; Laura Rubbia-Brandt; Patrycja Nowak-Sliwinska
Journal:  Cancers (Basel)       Date:  2022-09-30       Impact factor: 6.575

3.  Trends in Use and Perceptions About Triplet Chemotherapy Plus Bevacizumab for Metastatic Colorectal Cancer.

Authors:  Sietske C van Nassau; Marinde J Bond; Ilva Scheerman; Jesper van Breeschoten; Rob Kessels; Liselot B Valkenburg-van Iersel; Henk M Verheul; Tineke E Buffart; Leonie J Mekenkamp; Valery E Lemmens; Miriam Koopman; Guus M Bol
Journal:  JAMA Netw Open       Date:  2021-09-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.